Takeda Says 2nd Circ. Zanaflex Ruling Torpedoes Actos Row
Takeda told the Second Circuit on Tuesday that the panel's May ruling in a dispute over multiple sclerosis drug Zanaflex undermines a bid by buyers of the diabetes drug Actos to...To view the full article, register now.
Already a subscriber? Click here to view full article